Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2012
12/13/2012US20120315634 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
12/13/2012US20120315629 Cloning and Expression of arNOX Protein Transmembrane 9 Superfamily (TM9SF), Methods and Utility
12/13/2012US20120315323 Influenza hemagglutinin antibodies, compositions and related methods
12/13/2012US20120315321 Immunological methods and compositions for the treatment of alzheimer's disease
12/13/2012US20120315287 Mic-binding antibodies and methods of use thereof
12/13/2012US20120315286 Compositions and methods related to tim 3, a th1-specific cell surface molecule
12/13/2012US20120315282 Antibodies Specific for TGF-Beta
12/13/2012US20120315278 Human binding molecules having killing activity against enterococci and uses thereof
12/13/2012US20120315276 Neutralizing prolactin receptor antibodies and their therapeutic use
12/13/2012US20120315272 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
12/13/2012US20120315271 Methods for treating bone cancer by administering a nerve growth factor antagonist antibody
12/13/2012US20120315270 Rsv immunogens, antibodies and compositions thereof
12/13/2012US20120315267 Novel uses
12/13/2012CA2838497A1 Therapeutic antibodies
12/13/2012CA2838211A1 Anti-pseudomonas psl binding molecules and uses thereof
12/13/2012CA2837767A1 Cetp fragments
12/13/2012CA2837473A1 Human antigen binding proteins that bind to a complex comprising .beta.-klotho and an fgf receptor
12/13/2012CA2837357A1 Anti-ricin antibodies and uses thereof
12/13/2012CA2836373A1 Mcam antagonists and methods of treatment
12/13/2012CA2835231A1 Binding compounds to human .beta.1-adrenoreceptor (.beta.1-ar) and their use in the measurement of auto-anti-.beta.1-ar antibodies
12/12/2012EP2533052A1 Diagnostic use of proSomatostatin
12/12/2012EP2532743A1 Pharmaceutical composition for treatment and/or prevention of cancer
12/12/2012EP2532737A2 Cell culture improvements
12/12/2012EP2532681A1 Anti-ILT7 antibody
12/12/2012EP2532680A1 Medicinal composition for treating and/or preventing cancer
12/12/2012EP2532679A1 Human antibodies against il13 and therapeutic uses
12/12/2012EP2532678A1 Human antibodies against il13 and therapeutic uses
12/12/2012EP2532677A1 Human antibodies against il13 and therapeutic uses
12/12/2012EP2532676A1 Protease-regulated antibody
12/12/2012EP2532367A1 Pharmaceutical agent for treatment and/or prevention of cancer
12/12/2012EP2532366A1 Pharmaceutical composition for treating and/or preventing cancer
12/12/2012EP2532365A1 Pharmaceutical composition for treatment and/or prevention of cancer
12/12/2012EP2532364A1 Pharmaceutical composition for treating and/or preventing cancer
12/12/2012EP2532359A1 CETP fragments
12/12/2012EP2531853A2 Use of novel markers of pluripotent stem cells
12/12/2012EP2531527A1 A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma
12/12/2012EP2531526A1 Process for obtaining antibodies
12/12/2012EP2531525A1 In vitro process for the preparation of antibodies of the igg type
12/12/2012EP2531523A1 Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same
12/12/2012EP2531217A1 Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
12/12/2012EP2531213A2 Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination
12/12/2012CN1964990B Antibodies specific for glycoprotein VI and methods of producing these antibodies
12/12/2012CN1890567B Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer
12/12/2012CN1678734B Differentiation modulating agents and uses thereof
12/12/2012CN1484650B Urocortin proteins and uses thereof
12/12/2012CN1468311B Isomaltulose synthase
12/12/2012CN102822338A Novel monoclonal antibody and method for immunoassaying d dimer
12/12/2012CN102822335A Pharmaceutical composition for treatment and/or prevention of cancer
12/12/2012CN102822202A Antibodies that inhibit metalloproteins
12/12/2012CN102822201A Anti-HER3 antibodies and uses thereof
12/12/2012CN102822200A Combination of anti-CTLA4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
12/12/2012CN102822199A Medicinal composition for treating and/or preventing cancer
12/12/2012CN102822198A CTLA4 proteins and their uses
12/12/2012CN102821789A Pharmaceutical composition for treatment and/or prevention of cancer
12/12/2012CN102821788A Pharmaceutical composition for treatment and/or prevention of cancer
12/12/2012CN102821787A Antibody formulation and therapeutic regimens
12/12/2012CN102818896A Detection method of nitration modification sites based on specific antibodies and antibody capable of specifically recognizing succinyl-CoA: 3-oxoacid CoA transferase (SCOT) nitration sites
12/12/2012CN102816768A Prawn transcription activation reaction RNA binding protein and purpose thereof
12/12/2012CN102816743A Human ubiquitin ligase E3 for the modulation of NF-Kappa B
12/12/2012CN102816239A Specific composite IgY (immunoglobulin of yolk) for resisting human telomerase reverse transcriptase (hTERT) and human epidermal growth factor receptor-2 (HER2) and preparation method of specific composite IgY
12/12/2012CN102816238A IgG1 anti-human beta2-glycoprotein I monoclonal antibody, and preparation and application thereof
12/12/2012CN102816237A Preparation method of human anti-D immunoglobulin
12/12/2012CN102816236A Anti-NPC2 monoclonal antibodies and method of detecting fatty liver tissues, cancer cells or cancer tissues utilizing the same
12/12/2012CN102816235A Preparation method of hybrid tumor of monoclonal antibody inhibiting common bacillus thuringiensis CryI, and application of monoclonal antibody thereof
12/12/2012CN102816234A Peptide, use of the peptide, method for production of the peptide, solid phase having the peptide immobilized thereon, and method for production of the solid phase
12/12/2012CN102816229A Two cefotaxime sodium-bovine serum albumin conjugates, and preparation methods thereof
12/12/2012CN102199212B Monoclonal antibody against mucus immunoglobulin in flounder and preparation method thereof
12/12/2012CN101633695B Preparation method of anti-erbB2 functional antibody based on erbB2 protein extracellular C-terminal functional epitope characteristics
12/12/2012CN101511869B Anti-MCP-1 antibodies, compositions, methods and uses
12/12/2012CN101506236B Monoclonal antibodies against amyloid beta protein and uses thereof
12/12/2012CN101426816B Antibodies against human il-22 and uses thereof
12/12/2012CN101027390B Lrp4/Corin dopamine-producing neuron precursor cell marker
12/11/2012US8332159 Method for enhancing efficacy of preparation of monoclonal antibody
12/11/2012US8330026 Derivatives of the NF-κB inducing enzyme, their preparation and use
12/11/2012US8329981 Genetically modified non-human mammals and cells
12/11/2012US8329886 Nucleic acid molecules encoding anti-amyloid beta antibodies
12/11/2012US8329885 Nucleic acid encoding a T2R taste receptor
12/11/2012US8329877 Methods for separating recombinant proteins in aqueous two-phase systems
12/11/2012US8329874 Detection of specific nitrated markers
12/11/2012US8329873 Bispecific single chain Fv antibody molecules and methods of use thereof
12/11/2012US8329870 Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
12/11/2012US8329865 Antimicrobially active peptides
12/11/2012US8329660 Tim-3 (t cell immunoglobulin and mucin domain containing molecule) polypeptide for use in enhancement of immune and transplantaion tolerance
12/11/2012US8329640 Peptides with improved properties having the biological activity of vasoactive intestinal peptide (VIP) and their use for the treatment of lung diseases
12/11/2012US8329443 Antibody composition-producing cell
12/11/2012US8329431 Nucleic acid molecules encoding neutralising antibodies having specificity for human IL-17
12/11/2012US8329416 Stabilized standards for busulfan immunoassay
12/11/2012US8329409 Methods, kits, and antibodies for detecting parathyroid hormone
12/11/2012US8329396 Cloned DNA sequences hybridizable with genomic RNA of lymphadenopathy associated virus (LAV)
12/11/2012US8329182 Immunoglobulin chimeric monomer-dimer hybrids
12/11/2012US8329181 Methods for treating B-cell lymphoma by administering an anti-CD20 antibody
12/11/2012US8329180 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
12/11/2012US8329179 Death domain containing receptor 4 antibodies and methods
12/11/2012US8329178 Antibodies against CXCR4 and methods of use thereof
12/11/2012US8329177 Method of treating hypertrophic cardiomyopathy
12/11/2012US8329175 Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders
12/11/2012US8329174 Anti-hepcidin antibodies and uses thereof
12/11/2012US8329172 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
12/11/2012US8329171 Method for treating psoriatic arthritis by administering an anti-IL-12 antibody
12/11/2012US8329169 Methods and compositions for the prevention and treatment of sepsis
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 1494